← Insider buys
RARE

Ultragenyx Pharmaceutical Inc. · Healthcare

EVP and General Counsel Karah Herdman Parschauer sold $197K of Ultragenyx Pharmaceutical Inc.

Sold$197,010
$45.00Price
4,378Shares
−8%Stake

What RARE did after the filing

Filed May 5, copier in the same day
The stock from Fri, May 5 close, $47.22
+6.2%
S&P 500, same days
+6.3%

Measured over 30 trading days, to the Jun 20 close.

Traded Thu, May 4. Filed Fri, May 5, 2:16 PM ET, during the session. Returns use the May 5 close and the Jun 20 close. Not investment advice.